Clinical Trial Update: Perceval S Aortic Heart Valve Study- North America [NA]

View source ↗

Summary

The Perceval S Aortic Heart Valve North America trial (NCT01810679) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Regurgitation
• Aortic Valve Stenosis

Drugs mentioned

• Perceval S Aortic Heart Valve

Snippet

Sponsor: Sorin Group USA, Inc. | Conditions: Aortic Valve Stenosis, Aortic Valve Stenosis With Insufficiency | NA | Status: TERMINATED